Cell-cell communication network-based interpretable machine learning predicts cancer patient response to immune checkpoint inhibitors.
Source check: Source checked. Not independent scientific confirmation.
Finding / tested result: Interpretable machine learning on patient cell-cell communication networks predicted immune-checkpoint-inhibitor response across independent bulk and single-cell cohorts.
Technology: Materials and Methods describe network construction and cohort analyses; Results report response prediction across nine bulk and two single-cell cohorts.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Materials and Methods describe network construction and cohort analyses; Results report response prediction across nine bulk and two single-cell cohorts.
- Limitation / still unknown
- Independent bulk and single-cell cohorts support predictive associations, not causal cell-cell mechanisms or prospective treatment-selection benefit.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pmc&id=PMC10830106
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.